Miia M. Rytinki

1.0k citations
15 papers · 842 indexed · h-index 13
Topics
Ubiquitin and proteasome pathways (13 papers)Prostate Cancer Treatment and Research (6 papers)interferon and immune responses (2 papers)
Partner nations
FinlandSwedenEstonia

In The Last Decade

Miia M. Rytinki

15 papers receiving 826 citations

Peers

Miia M. Rytinki
Comparison fields: 5 of 70
  • Molecular Biology 693
  • Oncology 253
  • Pulmonary and Respiratory Medicine 132
  • Cancer Research 130
  • Genetics 117
Replace Jason Ho with:
Jason Ho Canada
Shruti Desai United States
Shuangyin Han China
Vincent Beuger United States
Olivier Kirsh France
Lidong Sun China
Chunping Qiu China
Abdol Hossein Rezaeian United States
Rebecca S. Levin United States
Miia M. Rytinki relative to Jason Ho Canada Jason Ho's profile →
Citations per field
00.5×1.5×2.3×
Jason Ho · 1×
Citations per year

Countries citing papers authored by Miia M. Rytinki

Since Specialization
Citations

This map shows the geographic impact of Miia M. Rytinki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miia M. Rytinki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miia M. Rytinki more than expected).

Fields of papers citing papers by Miia M. Rytinki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miia M. Rytinki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miia M. Rytinki. The network helps show where Miia M. Rytinki may publish in the future.

Co-authorship network of co-authors of Miia M. Rytinki

This figure shows the co-authorship network connecting the top 25 collaborators of Miia M. Rytinki. A scholar is included among the top collaborators of Miia M. Rytinki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miia M. Rytinki. Miia M. Rytinki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 51
2 33
3 38
4 17
5 16
6 12
7 15
8 4
9 92
10 235
11 45
12 43
13 40
14 87
15 114

About Miia M. Rytinki

Miia M. Rytinki is a scholar working on Aging, Cancer Research and Molecular Biology, having authored 15 papers that have together received 842 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (13 papers), Prostate Cancer Treatment and Research (6 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Molecular Biology (693 citations), Oncology (253 citations) and Cancer Research (130 citations). Miia M. Rytinki has collaborated with scholars based in Finland, Sweden and Estonia. Frequent co-authors include Jorma J. Palvimo, Sanna Kaikkonen, Tiina Jääskeläinen, Petri Pehkonen, Harri Makkonen, Ulla Karvonen, Päivi Sutinen, Shen Yan, Bryce M. Paschal and Ulrika Ottander. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026